Symbols / QNTM $3.61 -9.30% Quantum BioPharma Ltd.

Healthcare • Biotechnology • Canada • NCM
QNTM Chart
About

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 21.36M
Enterprise Value 12.94M Income -26.18M Sales —
Book/sh 1.81 Cash/sh 0.62 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -0.46 PEG —
P/S — P/B 2.00 P/C —
EV/EBITDA -0.88 EV/Sales — Quick Ratio 0.43
Current Ratio 1.07 Debt/Eq 36.77 LT Debt/Eq —
EPS (ttm) -8.20 EPS next Y -7.80 EPS Growth —
Revenue Growth — Earnings 2025-11-06 16:00 ROA -67.64%
ROE -3.47% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 5.83M
Shs Float 3.44M Short Float 6.04% Short Ratio 0.88
Short Interest — 52W High 38.25 52W Low 2.07
Beta — Avg Volume 299.16K Volume 179.09K
Target Price $12.54 Recom Strong_buy Prev Close $3.98
Price $3.61 Change -9.30%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$12.54
Mean price target
2. Current target
$3.61
Latest analyst target
3. DCF / Fair value
$-22.82
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.61
Low
$12.54
High
$12.54
Mean
$12.54
News
RSS: Latest QNTM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 Carroll (Donal) Director of Issuer — 100,000 $2.19 $218,600
2026-03-20 Durkacz (Anthony John) 10% Security Holder of Issuer — 100,000 $2.19 $218,600
2026-03-20 Saeed (Zeeshan) Director of Issuer — 100,000 $2.19 $218,600
2026-03-12 Carroll (Donal) Director of Issuer — 14,805 $2.10 $31,046
2026-03-12 Durkacz (Anthony John) 10% Security Holder of Issuer — 14,805 $2.10 $31,046
2026-03-12 Saeed (Zeeshan) Director of Issuer — 14,805 $2.10 $31,046
2025-12-10 Durkacz (Anthony John) 10% Security Holder of Issuer — 15 $18.12 $271
2025-12-10 Saeed (Zeeshan) Director of Issuer — 15 $18.12 $271
2025-11-26 Carroll (Donal) Director of Issuer — 6,967 $9.82 $68,415
2025-11-26 Carroll (Donal) Director of Issuer — 500 $9.48 $4,739
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
15.32
-3.57%
15.88
-18.84%
19.57
-28.65%
27.43
Research And Development
2.76
-54.58%
6.08
+57.63%
3.86
-44.16%
6.91
Selling General And Administration
12.01
+28.98%
9.31
-29.49%
13.20
-17.37%
15.98
General And Administrative Expense
12.01
+28.98%
9.31
-29.49%
13.20
-17.37%
15.98
Salaries And Wages
5.15
+83.23%
2.81
-50.61%
5.69
+271.63%
1.53
Other Gand A
6.86
+5.53%
6.50
-13.50%
7.51
-48.00%
14.45
Total Expenses
15.32
-3.57%
15.88
-18.84%
19.57
-28.65%
27.43
Operating Income
-15.32
+3.57%
-15.88
+18.84%
-19.57
+28.65%
-27.43
Total Operating Income As Reported
-15.30
+5.17%
-16.14
+32.17%
-23.79
+13.27%
-27.43
EBITDA
-25.79
-79.40%
-14.38
+8.56%
-15.72
+28.91%
-22.12
Normalized EBITDA
-14.08
+4.98%
-14.82
-30.68%
-11.34
+49.39%
-22.41
Reconciled Depreciation
0.55
+11.25%
0.49
-80.43%
2.51
-44.73%
4.53
EBIT
-26.34
-77.15%
-14.87
+18.44%
-18.23
+31.61%
-26.65
Total Unusual Items
-11.71
-2766.90%
0.44
+110.01%
-4.39
-1624.97%
0.29
Total Unusual Items Excluding Goodwill
-11.71
-2766.90%
0.44
+110.01%
-4.39
-1624.97%
0.29
Special Income Charges
0.04
-94.08%
0.73
+116.08%
-4.56
0.00
Other Special Charges
-0.04
+94.08%
-0.73
—
—
Impairment Of Capital Assets
0.00
0.00
-100.00%
4.56
0.00
Net Income
-26.18
-84.30%
-14.20
+20.66%
-17.90
+24.17%
-23.61
Pretax Income
-26.96
-80.73%
-14.92
+18.18%
-18.23
+31.73%
-26.70
Net Non Operating Interest Income Expense
-0.38
-172.82%
0.53
-33.17%
0.79
+146.48%
0.32
Interest Expense Non Operating
0.62
+1200.29%
0.05
+15812.04%
0.00
-99.39%
0.05
Net Interest Income
-0.38
-172.82%
0.53
-33.17%
0.79
+146.48%
0.32
Interest Expense
0.62
+1200.29%
0.05
+15812.04%
0.00
-99.39%
0.05
Interest Income Non Operating
0.24
-58.79%
0.57
-27.15%
0.79
+113.84%
0.37
Interest Income
0.24
-58.79%
0.57
-27.15%
0.79
+113.84%
0.37
Other Income Expense
-11.26
-2639.96%
0.44
-19.92%
0.55
+35.97%
0.41
Other Non Operating Income Expenses
0.46
+11336.78%
0.00
-99.92%
4.94
+4034.69%
0.12
Gain On Sale Of Security
-11.76
-3909.49%
-0.29
-272.22%
0.17
-40.80%
0.29
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-26.96
-80.73%
-14.92
+18.18%
-18.23
+22.77%
-23.61
Net Income From Continuing Operation Net Minority Interest
-26.18
-84.30%
-14.20
+20.66%
-17.90
+32.96%
-26.70
Net Income From Continuing And Discontinued Operation
-26.18
-84.30%
-14.20
+20.66%
-17.90
+24.17%
-23.61
Net Income Continuous Operations
-26.96
-80.73%
-14.92
+18.18%
-18.23
+31.73%
-26.70
Net Income Discontinuous Operations
—
0.00
0.00
-100.00%
3.10
Minority Interests
0.78
+9.64%
0.71
+117.05%
0.33
0.00
Normalized Income
-14.46
+1.23%
-14.64
-8.33%
-13.52
+49.92%
-26.99
Net Income Common Stockholders
-26.18
-84.30%
-14.20
+20.66%
-17.90
+24.17%
-23.61
Diluted EPS
-8.20
+37.50%
-13.12
+56.16%
-29.93
+24.44%
-39.61
Basic EPS
-8.20
+37.50%
-13.12
+56.16%
-29.93
+24.44%
-39.61
Basic Average Shares
3.29
+189.02%
1.14
+86.67%
0.61
+2.21%
0.60
Diluted Average Shares
3.29
+189.02%
1.14
+86.67%
0.61
+2.21%
0.60
Diluted NI Availto Com Stockholders
-26.18
-84.30%
-14.20
+20.66%
-17.90
+24.17%
-23.61
Depreciation Amortization Depletion Income Statement
0.55
+11.25%
0.49
-80.43%
2.51
-44.76%
4.54
Depreciation And Amortization In Income Statement
0.55
+11.25%
0.49
-80.43%
2.51
-44.76%
4.54
Line Item Trend 2023-12-31
Total Assets
17.47
Current Assets
11.09
Cash Cash Equivalents And Short Term Investments
3.51
Cash And Cash Equivalents
2.76
Cash Financial
—
Other Short Term Investments
0.76
Receivables
7.42
Other Receivables
0.00
Taxes Receivable
0.21
Accrued Interest Receivable
0.02
Loans Receivable
7.19
Inventory
0.00
Raw Materials
—
Finished Goods
—
Prepaid Assets
0.16
Restricted Cash
—
Assets Held For Sale Current
—
Other Current Assets
—
Total Non Current Assets
6.39
Net PPE
0.12
Gross PPE
0.12
Other Properties
0.12
Goodwill And Other Intangible Assets
5.36
Other Intangible Assets
5.36
Investments And Advances
0.01
Other Investments
0.01
Non Current Accounts Receivable
0.91
Total Liabilities Net Minority Interest
4.57
Current Liabilities
4.57
Payables And Accrued Expenses
4.20
Payables
3.24
Accounts Payable
3.24
Other Payable
—
Current Accrued Expenses
0.95
Pensionand Other Post Retirement Benefit Plans Current
—
Current Debt And Capital Lease Obligation
0.34
Current Debt
0.30
Other Current Borrowings
—
Current Capital Lease Obligation
0.04
Current Deferred Liabilities
0.00
Current Deferred Revenue
0.00
Other Current Liabilities
0.03
Total Non Current Liabilities Net Minority Interest
0.00
Long Term Debt And Capital Lease Obligation
0.00
Long Term Capital Lease Obligation
0.00
Stockholders Equity
13.24
Common Stock Equity
13.24
Capital Stock
137.78
Common Stock
137.78
Share Issued
0.61
Ordinary Shares Number
0.61
Treasury Shares Number
0.00
Additional Paid In Capital
30.23
Retained Earnings
-157.91
Gains Losses Not Affecting Retained Earnings
0.42
Minority Interest
-0.33
Total Equity Gross Minority Interest
12.91
Total Capitalization
13.24
Working Capital
6.52
Invested Capital
13.54
Total Debt
0.34
Capital Lease Obligations
0.04
Net Tangible Assets
7.88
Tangible Book Value
7.88
Available For Sale Securities
0.01
Current Notes Payable
0.30
Foreign Currency Translation Adjustments
0.42
Interest Payable
0.41
Investmentin Financial Assets
0.01
Non Current Note Receivables
0.91
Other Equity Interest
2.72
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.24
-19.79%
-6.88
+36.49%
-10.83
+61.79%
-28.33
Cash Flow From Continuing Operating Activities
-8.24
-19.79%
-6.88
+36.49%
-10.83
+60.18%
-27.19
Cash From Discontinued Operating Activities
—
0.00
0.00
+100.00%
-1.14
Net Income From Continuing Operations
-26.96
-80.73%
-14.92
+18.18%
-18.23
+31.73%
-26.70
Depreciation Amortization Depletion
0.55
+11.25%
0.49
-80.43%
2.51
-44.73%
4.53
Depreciation
—
—
—
—
Depreciation And Amortization
0.55
+11.25%
0.49
-80.43%
2.51
-44.73%
4.53
Other Non Cash Items
2.13
+8826.60%
0.02
-1.59%
0.02
-40.46%
0.04
Stock Based Compensation
2.95
+1835.11%
0.15
-96.03%
3.84
+150.48%
1.53
Asset Impairment Charge
0.00
0.00
-100.00%
4.56
0.00
Operating Gains Losses
10.60
+518.85%
-2.53
+54.29%
-5.53
-1990.05%
0.29
Gain Loss On Investment Securities
11.14
+10762.42%
-0.10
+97.97%
-5.15
-703.30%
-0.64
Unrealized Gain Loss On Investment Securities
0.51
+253.27%
0.15
-61.56%
0.38
+61.56%
0.23
Net Foreign Currency Exchange Gain Loss
-0.50
+70.39%
-1.69
-341.40%
-0.38
-141.06%
0.93
Change In Working Capital
1.99
-79.65%
9.76
+495.72%
1.64
+123.00%
-7.12
Change In Receivables
1.69
-62.64%
4.52
+719.87%
-0.73
+89.90%
-7.22
Change In Inventory
0.07
+155.53%
-0.12
0.00
0.00
Change In Prepaid Assets
0.05
-37.78%
0.09
-72.73%
0.32
-60.21%
0.80
Change In Payables And Accrued Expense
1.18
-72.40%
4.27
+108.33%
2.05
+392.92%
-0.70
Change In Payable
1.18
-72.40%
4.27
+108.33%
2.05
+392.92%
-0.70
Change In Other Working Capital
-1.00
-200.00%
1.00
—
—
Investing Cash Flow
-1.95
-29.86%
-1.50
-457.74%
-0.27
-102.22%
12.12
Cash Flow From Continuing Investing Activities
-1.95
-29.86%
-1.50
-457.74%
-0.27
+55.63%
-0.61
Cash From Discontinued Investing Activities
—
0.00
0.00
-100.00%
12.73
Net PPE Purchase And Sale
—
0.00
0.00
+100.00%
-0.11
Purchase Of PPE
—
0.00
0.00
+100.00%
-0.11
Capital Expenditure
—
—
—
-0.36
Net Investment Purchase And Sale
-1.95
-29.86%
-1.50
-398.92%
-0.30
-23.72%
-0.24
Purchase Of Investment
-6.09
+20.77%
-7.69
-933.26%
-0.74
-85.38%
-0.40
Sale Of Investment
4.14
-33.07%
6.19
+1296.65%
0.44
+180.40%
0.16
Net Business Purchase And Sale
0.00
0.00
-100.00%
0.03
0.00
Net Intangibles Purchase And Sale
—
0.00
0.00
+100.00%
-0.25
Purchase Of Intangibles
—
0.00
0.00
+100.00%
-0.25
Financing Cash Flow
6.10
-47.51%
11.62
+471.61%
-3.13
-51.09%
-2.07
Cash Flow From Continuing Financing Activities
6.10
-47.51%
11.62
+471.61%
-3.13
-51.09%
-2.07
Net Issuance Payments Of Debt
5.24
+452.88%
0.95
+601.58%
-0.19
-32.14%
-0.14
Issuance Of Debt
5.36
+429.39%
1.01
0.00
0.00
Repayment Of Debt
-0.11
-79.07%
-0.06
+66.37%
-0.19
-32.14%
-0.14
Long Term Debt Payments
-0.11
-79.07%
-0.06
+66.37%
-0.19
-32.14%
-0.14
Net Long Term Debt Issuance
-0.11
-79.07%
-0.06
+66.37%
-0.19
-32.14%
-0.14
Short Term Debt Issuance
5.36
+429.39%
1.01
0.00
0.00
Short Term Debt Payments
—
—
0.00
0.00
Net Short Term Debt Issuance
5.36
+429.39%
1.01
0.00
0.00
Net Common Stock Issuance
0.34
-96.83%
10.67
+460.76%
-2.96
-53.55%
-1.93
Common Stock Payments
0.00
0.00
+100.00%
-2.96
-53.55%
-1.93
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-2.96
-53.55%
-1.93
Proceeds From Stock Option Exercised
0.19
0.00
-100.00%
0.02
0.00
Net Other Financing Charges
0.33
—
—
—
Changes In Cash
-4.09
-226.30%
3.24
+122.77%
-14.22
+22.19%
-18.28
Beginning Cash Position
6.00
+117.47%
2.76
-83.76%
16.98
-51.84%
35.26
End Cash Position
1.91
-68.22%
6.00
+117.47%
2.76
-83.76%
16.98
Free Cash Flow
-8.24
-19.79%
-6.88
+36.49%
-10.83
+62.27%
-28.70
Common Stock Issuance
0.34
-96.83%
10.67
+31384070.59%
0.00
0.00
Issuance Of Capital Stock
0.34
-96.83%
10.67
+31384070.59%
0.00
0.00
Sale Of Business
0.00
0.00
-100.00%
0.03
0.00
Cash From Discontinued Financing Activities
—
—
—
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category